Source: BMC Gastroenterology. Unidades: FM, IME
Subjects: GASTOS EM SAÚDE, ESTATÍSTICA DESCRITIVA, INFERÊNCIA ESTATÍSTICA
ABNT
NAKANO, Larissa Akeme; CANÇADO, Eduardo Luiz Rachid; CHAVES, Cleuber Esteves; et al. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis. BMC Gastroenterology, London, BioMed Central, v. 20, n. artigo 253, p. 253-261, 2020. Disponível em: < https://doi.org/10.1186/s12876-020-01399-5 > DOI: 10.1186/s12876-020-01399-5.APA
Nakano, L. A., Cançado, E. L. R., Chaves, C. E., Madeira, M. C. V., Katayose, J. T., Nabeshima, M. A., et al. (2020). A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis. BMC Gastroenterology, 20( artigo 253), 253-261. doi:10.1186/s12876-020-01399-5NLM
Nakano LA, Cançado ELR, Chaves CE, Madeira MCV, Katayose JT, Nabeshima MA, Fossaluza V, Uhrigshardt GG, Liting Z, Pinto VB, Carrilho FJ, Ono SK. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis [Internet]. BMC Gastroenterology. 2020 ; 20( artigo 253): 253-261.Available from: https://doi.org/10.1186/s12876-020-01399-5Vancouver
Nakano LA, Cançado ELR, Chaves CE, Madeira MCV, Katayose JT, Nabeshima MA, Fossaluza V, Uhrigshardt GG, Liting Z, Pinto VB, Carrilho FJ, Ono SK. A randomized crossover trial to assess therapeutic efficacy and cost reduction of acid ursodeoxycholic manufactured by the university hospital for the treatment of primary biliary cholangitis [Internet]. BMC Gastroenterology. 2020 ; 20( artigo 253): 253-261.Available from: https://doi.org/10.1186/s12876-020-01399-5